Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
62M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
+2.09M
-
Total reported value, excl. options
-
$546M
-
Value change
-
+$34.4M
-
Put/Call ratio
-
1.41
-
Number of buys
-
58
-
Number of sells
-
-36
-
Price
-
$17.51
Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q2 2017
124 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q2 2017.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
of 62M outstanding shares and own 50.29% of the company stock.
Largest 10 shareholders include FMR LLC (5.24M shares), OppenheimerFunds, Inc. (3.58M shares), BlackRock Inc. (2.6M shares), BB BIOTECH AG (2.35M shares), Boxer Capital, LLC (2.12M shares), VANGUARD GROUP INC (1.39M shares), Point72 Asset Management, L.P. (1.08M shares), InterWest Venture Management Co (1.07M shares), WASATCH ADVISORS INC (1.04M shares), and STATE STREET CORP (969K shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.